by FiveSenses | Mar 26, 2024 | News Release
Vancouver, BC, Canada, March 26th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biotechnology company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to... 
by FiveSenses | Mar 26, 2024 | News Release
Vancouver, BC, Canada, March 22nd, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2nd... 
by FiveSenses | Mar 4, 2024 | News Release
Vancouver, BC, Canada, March 4th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the granting of US patent...
Recent Comments